跳至主要内容
临床试验/CTRI/2023/04/051341
CTRI/2023/04/051341尚未招募Unknown

A study to assess the outcome of preoperaive supplemenatation of beta-hydroxy-beta-methyl butyrate (HMB) in cardiac surgery using cardiopulmonary bypass (CPB)

The Madras Medical Mission, Chennai0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Elective Cardiac surgery using cardiopulmonary bypass
  • Patients with adequate LV function
  • Patients with mild to moderate LV dysfunction

排除标准

  • Patients with
  • Severe LV dysfunction
  • Preexisting kidney disease
  • Preexisting liver disease
  • Smoking, drug/alcohol abuse
  • Hepatitis B & C infection
  • Endocrine disorders
  • Autoimmune disorders
  • Patients already on protein supplementation
  • Offpump cardiac surgeries
  • Patient refusal

研究者

发起方
The Madras Medical Mission, Chennai

相似试验